INVALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒═══════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                 │ CHIA Criteria                                      │   Score │
╞═══════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Children aged 0-59 months living with families    │ Children aged 0-59 months living with families     │     100 │
│ registered in the rural Bandim Health Project     │ registered in the rural Bandim Health Project      │         │
│ Health and Demographic Surveillance Site are      │ Health and Demographic Surveillance Site are       │         │
│ included, provided a parent/guardian consent      │ included, provided a parent/guardian consent       │         │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ the child has as a mid upper arm circumference \< │ the child has as a mid upper arm circumference <   │     100 │
│ 110 mm and is older than 6 months (most feasible  │ 110 mm and is older than 6 months (most feasible   │         │
│ local indicator of AIDS and chronic               │ local indicator of AIDS and chronic                │         │
│ immunosuppressive disease)                        │ immunosuppressive disease)                         │         │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ the child has experienced a severe allergic       │ the child has experienced a severe allergic        │     100 │
│ reaction after previous vaccination, drug or food │ reaction after previous vaccination, drug or food  │         │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ For the RECAMP-MV trial: the child is enrolled in │ For the RECAMP-MV trial: the child is enrolled in  │     100 │
│ RECAMP-OPV                                        │ RECAMP-OPV                                         │         │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ the child has temperature \> 39.0◦C or a severe   │ the child has temperature > 39.0◦C or a severe     │      99 │
│ acute illness as defined by the examining nurse   │ acute illness as defined by the examining nurse    │         │
├───────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ the child is enrolled in an ongoing study of      │ the child is enrolled in an ongoing study of       │      99 │
│ Bacillus Calmette Guerin vaccine and is \< 2      │ Bacillus Calmette Guerin vaccine and is < 2 months │         │
│ months old                                        │ old                                                │         │
╘═══════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ OR                                 │ For the RECAMP-MV trial: the child is enrolled in  │       3 │
│                                    │ RECAMP-OPV                                         │         │
├────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ OR                                 │ For the RECAMP-MV trial: the child is enrolled in  │       3 │
│                                    │ RECAMP-OPV                                         │         │
├────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ OR                                 │ For the RECAMP-MV trial: the child is enrolled in  │       3 │
│                                    │ RECAMP-OPV                                         │         │
├────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ OR                                 │ For the RECAMP-MV trial: the child is enrolled in  │       3 │
│                                    │ RECAMP-OPV                                         │         │
├────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Must have maximum age of 59 Months │ the child is enrolled in an ongoing study of       │      30 │
│                                    │ Bacillus Calmette Guerin vaccine and is < 2 months │         │
│                                    │ old                                                │         │
├────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 0 Months  │ the child is enrolled in an ongoing study of       │      32 │
│                                    │ Bacillus Calmette Guerin vaccine and is < 2 months │         │
│                                    │ old                                                │         │
╘════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 94
Average Levenshtein Ratio of individual lines: 56.0
OverAll Ratio: 75.0
